Hydrocodone Bitartrate 8 mg Oral Capsules are solid dosage forms consisting of two halves of either gelatin or vegetarian-based shells. These capsules are designed to enclose a precise 8 mg dose of the active ingredient, hydrocodone bitartrate, which is a potent opioid analgesic. The encapsulation of the medication ensures ease of administration and aids in the convenience of swallowing.
This formulation is specifically used for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. It is also indicated for the relief of cough in adults. Due to the risk of addiction, abuse, and misuse, this medication should only be used in patients for whom the benefits outweigh the risks and should be prescribed at the lowest effective dose for the shortest duration consistent with individual patient treatment goals.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Hydrocodone Bitartrate 8 mg Oral Capsules are a solid dosage form consisting of two halves of either gelatin or vegetarian-based shells that are filled with the precise amount of the active ingredient, hydrocodone bitartrate. This opioid analgesic is designed for the management of severe pain that is not responsive to alternative, less potent analgesics. Hydrocodone works by binding to the mu-opioid receptors in the brain and spinal cord, altering the perception and emotional response to pain. It is also known to have cough suppressant effects. The encapsulation of hydrocodone bitartrate in capsule form allows for ease of administration and ensures that patients receive an accurate dose of the medication.
Hydrocodone Bitartrate 8 mg Oral Capsules are indicated for the relief of moderate to severe pain where the use of an opioid analgesic is appropriate. The use of this medication should be strictly according to the prescription by a healthcare professional, as hydrocodone has a high potential for abuse, addiction, and serious side effects if not used properly. It is essential for prescribers to evaluate the patient's history, the severity of the pain, and the patient's response to treatment when considering the use of hydrocodone. Additionally, prescribers should monitor patients for signs of addiction, abuse, and misuse.
Patients should be advised of the potential side effects of hydrocodone, which may include drowsiness, dizziness, nausea, vomiting, constipation, and respiratory depression. It is important for patients to take the medication exactly as prescribed and to keep it out of reach of children and individuals for whom it was not prescribed. Patients should also be informed of the potential for serious drug interactions with other CNS depressants and alcohol. It is crucial to avoid engaging in activities requiring mental alertness, such as driving or operating heavy machinery, while taking this medication.
For any questions or concerns regarding Hydrocodone Bitartrate 8 mg Oral Capsules, or to discuss the appropriateness of this medication for a particular patient, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing comprehensive information and support to both patients and prescribers to ensure the safe and appropriate use of this medication.
Hydrocodone bitartrate is an opioid analgesic used for the relief of moderate to severe pain. As with all opioids, hydrocodone has the potential to interact with a wide range of drugs, which can lead to increased risk of serious side effects or reduced therapeutic efficacy. It is important for both patients and prescribers to be aware of these potential interactions.
One of the most significant interactions is with central nervous system (CNS) depressants, including other opioids, benzodiazepines, muscle relaxants, sedatives, hypnotics, anxiolytics, and alcohol. Concurrent use of these substances with hydrocodone can lead to additive CNS depression, resulting in profound sedation, respiratory depression, coma, or even death. Patients should be closely monitored and the use of such combinations should be avoided or undertaken with extreme caution.
Hydrocodone also interacts with monoamine oxidase inhibitors (MAOIs). Patients taking MAOIs or within 14 days of stopping such treatment may experience serotonin syndrome or opioid toxicity, including confusion, hyperactivity, and significant changes in blood pressure. Extreme caution is advised when considering hydrocodone for patients with a history of MAOI use.
Anticholinergic drugs can exacerbate the constipation commonly caused by opioids like hydrocodone. Additionally, anticholinergic effects on the central nervous system may be increased, leading to increased risk of urinary retention and/or severe constipation, which can lead to paralytic ileus.
Drugs that affect the cytochrome P450 3A4 (CYP3A4) enzyme system can alter the metabolism of hydrocodone. Inhibitors of CYP3A4 such as ketoconazole, erythromycin, and ritonavir may increase hydrocodone plasma concentrations, leading to increased or prolonged opioid effects. Conversely, inducers of CYP3A4 such as rifampin, carbamazepine, and phenytoin may reduce the efficacy of hydrocodone by increasing its metabolism.
Hydrocodone may also interact with serotonergic medications, including selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), and triptans, among others. Such interactions can lead to the development of serotonin syndrome, a potentially life-threatening condition. Symptoms of serotonin syndrome may include mental status changes, autonomic instability, neuromuscular aberrations, and/or gastrointestinal symptoms.
Patients receiving hydrocodone should be advised to inform their healthcare provider of all medications they are taking, including prescription drugs, over-the-counter medications, herbal supplements, and vitamins to avoid potential drug interactions. Prescribers should carefully evaluate the patient's medication regimen for possible interactions and adjust therapy accordingly to ensure safe and appropriate use of hydrocodone.
If you have any questions or require further information regarding drug interactions with hydrocodone bitartrate 8 mg oral capsules, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide the necessary support and guidance.
Hydrocodone bitartrate 8 mg oral capsules are a solid dosage form designed to deliver a specific dose of hydrocodone, which is an opioid analgesic. These capsules consist of two halves, typically made from gelatin or a vegetarian substitute, that are filled with the active medication and then sealed together. This design allows for the medication to be ingested easily and to dissolve or disintegrate in the stomach, releasing the hydrocodone for absorption into the bloodstream.
Hydrocodone works by binding to the mu-opioid receptors in the brain and spinal cord, which are part of the central nervous system. By attaching to these receptors, hydrocodone can effectively alter the body's perception of pain, providing relief. It also has effects on the cough center in the brain, leading to a reduction in cough reflex, although this is not the primary indication for this dosage form.
The precise 8 mg dosage of hydrocodone in each capsule ensures that patients receive a consistent amount of medication with each dose, which is important for managing pain effectively. This is particularly beneficial for patients who require a stable regimen to manage chronic pain conditions. The encapsulated form also helps to mask any unpleasant taste of the medication, making it more palatable for the patient.
Hydrocodone bitartrate capsules are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. It is important to note that due to the risks of addiction, abuse, and misuse, even at recommended doses, hydrocodone should be prescribed only by healthcare professionals who are knowledgeable in the use of potent opioids for the management of chronic pain.
Patients should be aware that this medication can cause side effects such as drowsiness, dizziness, constipation, nausea, and vomiting. It is also important for patients to take the medication exactly as prescribed and to keep it out of reach of children and individuals for whom it was not prescribed. Due to the potential for serious adverse effects, including overdose and death, it is crucial that patients understand the importance of adhering to the dosing regimen and the risks associated with improper use.
For prescribers considering hydrocodone bitartrate 8 mg oral capsules for their patients, it is essential to assess each patient's risk for opioid addiction, abuse, or misuse prior to prescribing. Prescribers should monitor patients closely for signs of addiction, abuse, and misuse while on opioid analgesic therapy. Additionally, prescribers should educate patients and caregivers about the safe use, serious risks, storage, and disposal of these medications.
If you have any questions or require further information about hydrocodone bitartrate 8 mg oral capsules, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide the support and guidance needed to ensure the safe and appropriate use of this medication.
Hydrocodone bitartrate 8 mg oral capsules are primarily indicated for the relief of moderate to severe pain where the use of an opioid analgesic is appropriate. The efficacy of hydrocodone in treating pain is well-established, but there are other considerations for its use that prescribers and patients may find valuable. While the primary indication for hydrocodone is pain management, occasionally, it is also prescribed off-label to manage coughing in situations where traditional antitussives might be ineffective or contraindicated. This usage would only be appropriate under the strict guidance of a physician and in a formulation suited for cough suppression.
Additionally, hydrocodone may be used as part of palliative care to improve the quality of life for patients with terminal illnesses, by controlling pain that cannot be managed by non-opioid pain relievers. Hydrocodone may also have anxiolytic effects which can be a secondary benefit for patients who experience pain-induced anxiety; however, this is not a primary indication for its use, and anti-anxiety effects should not be expected or relied upon.
It should be noted that hydrocodone has a potential for abuse and dependence, thus its use should be carefully monitored by a healthcare professional. These oral capsules provide a fixed dosage, which is essential for maintaining consistent plasma levels of the drug, but this form does not allow for dose titration. For patients or prescribers requiring adjustable dosing, a different formulation would be necessary.
In all cases of off-label use, the decision to prescribe hydrocodone should be made with careful consideration of the risks and benefits, and with close monitoring for signs of abuse, addiction, and adverse effects. Additionally, because of the potential for significant interactions with other medications and contraindications in certain patient populations, a thorough review of the patient's medical history and current medications is imperative before initiating therapy with hydrocodone. If you have any questions about the potential other uses for hydrocodone bitartrate 8 mg oral capsules, or if you have specific patient cases that require expert advice, please reach out to us at Bayview Pharmacy.
Hydrocodone Bitartrate 8 mg Oral Capsule is a prescription medication used to relieve moderate to severe pain. It contains hydrocodone bitartrate, which is an opioid analgesic.
You should take Hydrocodone Bitartrate 8 mg Oral Capsules exactly as prescribed by your doctor. The capsules should be swallowed whole with water and can be taken with or without food. Do not chew, break, or crush the capsules.
The capsule shells can be made of either gelatin or a vegetarian alternative. Both options are designed for easy swallowing and to encase the medication safely.
No, you should not open the Hydrocodone Bitartrate 8 mg Oral Capsule. Opening the capsule can affect the way the medication is absorbed and how it works.
If you miss a dose of Hydrocodone Bitartrate 8 mg Oral Capsules, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up.
Yes, like all medications, Hydrocodone Bitartrate 8 mg Oral Capsules can cause side effects. Common side effects include nausea, vomiting, constipation, drowsiness, and dizziness. If you experience severe side effects or signs of an allergic reaction, seek medical attention immediately.
No, you should avoid consuming alcohol while taking Hydrocodone Bitartrate 8 mg Oral Capsules, as it can increase the risk of serious side effects such as severe drowsiness, dizziness, and respiratory depression.
Yes, Hydrocodone Bitartrate is an opioid, which can be habit-forming. It's important to take it exactly as prescribed by your healthcare provider to reduce the risk of addiction or abuse.
Since Hydrocodone Bitartrate 8 mg Oral Capsules can cause drowsiness, dizziness, or impair your thinking and reactions, you should not drive or operate heavy machinery until you know how the medication affects you.
Store Hydrocodone Bitartrate 8 mg Oral Capsules at room temperature away from light and moisture. Keep the medication out of reach of children and pets. Do not keep it in the bathroom or near a sink.
If you suspect an overdose of Hydrocodone Bitartrate 8 mg Oral Capsules, seek emergency medical attention immediately. An overdose of hydrocodone can be fatal, especially in a child or another person using the medicine without a prescription.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth